InsiderClue
Insiders · Profile

Attar Eyal C.

CHIEF MEDICAL OFFICER at Vor Biopharma · SVP, Chief Medical Officer at Aprea Therapeutics. Filing since 7 Oct 2019. CIK 0001789076

VOR Vor Biopharma Inc. CHIEF MEDICAL OFFICER · 4 trades APRE Aprea Therapeutics, Inc. SVP, Chief Medical Officer · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VOR Vor Biopharma Inc.
13 Feb 2025
CHIEF MEDICAL OFFICER
Sold on a plan
2,227
$3.16K
1.7%
VOR Vor Biopharma Inc.
10 Feb 2025
CHIEF MEDICAL OFFICER
Sold on a plan
2,554
$3.50K
1.9%
VOR Vor Biopharma Inc.
27 Dec 2024
CHIEF MEDICAL OFFICER
Sold on a plan
10,334
$12.92K
11.3%
VOR Vor Biopharma Inc.
3 Jun 2024
CHIEF MEDICAL OFFICER
Sold on a plan
14,645
$20.36K
13.2%
APRE Aprea Therapeutics, Inc.
28 Feb 2022
SVP, Chief Medical Officer
Sold, plan not stated
36,000
$62.28K
43.4%
APRE Aprea Therapeutics, Inc.
16 Sep 2021
SVP, Chief Medical Officer
Sold, plan not stated
15,968
$74.73K
16.1%
APRE Aprea Therapeutics, Inc.
7 Oct 2019
SVP, Chief Medical Officer
Bought
200
$3.00K
opened
APRE Aprea Therapeutics, Inc.
7 Oct 2019
SVP, Chief Medical Officer
Bought
200
$3.00K
opened
8 decisions on file.